National patterns of paroxetine use among US Medicare patients from 2015–2020
Bibliographic Data
| ID | 15526369 |
|---|---|
| Authors | Luke R Cavanah (0000-0002-0620-056X, Geisinger Commonwealth School of Medicine, corresponding author), Jessica L Goldhirsh (0000-0002-1825-2666, Geisinger Commonwealth School of Medicine), Leighton Y Huey (Clinton Health Access Initiative), Brian J Piper (0000-0002-2295-445X, Center for Innovation) |
| Year | 2024 |
| Volume | 15 |
| Pages | 1399493-1399493 |
| Publication date | 2024-07-10 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Frontiers in Psychiatry (JOURNAL) |
| Journal identifiers | ISSN: 1664-0640 • E-ISSN: 1664-0640 |
| Publisher | Frontiers Media (PUBLISHER • CH) |
| DOI | 10.3389/fpsyt.2024.1399493 |
| PMID | 39050917 |
| OpenAlex | W4400512513 |
| Language | EN |
| References cited | 35 |
Despite the American Geriatrics Society's prohibition against paroxetine use in older adults and many effective treatment alternatives, paroxetine was still commonly used in the US in this population, especially in Kentucky and North Dakota and by neuropsychiatry and geriatric medicine. These findings provide information on the specialty types and states where education and policy reform would likely have the greatest impact on improving adherence to the paroxetine prescription recommendations
Antidepressant · Anxiety · Medical prescription · Medicare Part D · Paroxetine · Psychiatry · Blood Pressure and Hypertension Studies · Medicine · Nursing · Pharmaceutical Practices and Patient Outcomes · Psychology · Treatment of Major Depression
| Citation velocity | historical |
|---|---|
| Highly cited | No |